Vascular Behçet syndrome: from pathogenesis to treatment
A Bettiol, F Alibaz-Oner, H Direskeneli… - Nature Reviews …, 2023 - nature.com
Behçet syndrome is a rare, chronic inflammatory disease of unknown aetiopathogenesis,
most commonly presenting with mucocutaneous and ocular manifestations. Vascular …
most commonly presenting with mucocutaneous and ocular manifestations. Vascular …
Behçet's disease: new insights into pathophysiology, clinical features and treatment options
Behçet's disease (BD) is a rare systemic vasculitis characterized by oral aphthous ulcers,
genital ulcers, ocular lesions and other systemic manifestations. BD occurs most frequently …
genital ulcers, ocular lesions and other systemic manifestations. BD occurs most frequently …
Single-cell analyses highlight the proinflammatory contribution of C1q-high monocytes to Behçet's disease
W Zheng, X Wang, J Liu, X Yu, L Li… - Proceedings of the …, 2022 - National Acad Sciences
Behçet's disease (BD) is a chronic vasculitis characterized by systemic immune aberrations.
However, a comprehensive understanding of immune disturbances in BD and how they …
However, a comprehensive understanding of immune disturbances in BD and how they …
Behçet's disease: an overview of etiopathogenesis
P Leccese, E Alpsoy - Frontiers in immunology, 2019 - frontiersin.org
Behçet's disease (BD) is a systemic inflammatory disease with a chronic, relapsing-remitting
course of unknown etiology hallmarked predominantly by mucocutaneous lesions and …
course of unknown etiology hallmarked predominantly by mucocutaneous lesions and …
Behçet's Syndrome
Behçet’s Syndrome | New England Journal of Medicine Skip to main content Access provided
byKuopion Yliopistollinen Sairaala The New England Journal of Medicine homepage Advanced …
byKuopion Yliopistollinen Sairaala The New England Journal of Medicine homepage Advanced …
[HTML][HTML] Trial of apremilast for oral ulcers in Behçet's syndrome
Background The small-molecule phosphodiesterase 4 inhibitor apremilast modulates
cytokines that are up-regulated in Behçet's syndrome. In a phase 2 trial involving patients …
cytokines that are up-regulated in Behçet's syndrome. In a phase 2 trial involving patients …
Behçet: the syndrome
A Bettiol, D Prisco, G Emmi - Rheumatology, 2020 - academic.oup.com
Behçet's syndrome (BS) is a systemic vasculitis characterized by a relapsing and remitting
course. It can involve the skin, mucosa, joints, vessels (arteries and/or veins), eyes, and …
course. It can involve the skin, mucosa, joints, vessels (arteries and/or veins), eyes, and …
Cluster analysis of phenotypes of patients with Behçet's syndrome: a large cohort study from a referral center in China
J Zou, J Luo, Y Shen, J Cai, J Guan - Arthritis research & therapy, 2021 - Springer
Introduction Behcet's syndrome (BS) is a complex, heterogeneous disorder. However,
classification of its subgroups is still debated. The purpose of this study was to investigate …
classification of its subgroups is still debated. The purpose of this study was to investigate …
Behçet syndrome
Y Yazici, G Hatemi, B Bodaghi, JH Cheon… - Nature Reviews …, 2021 - nature.com
Behçet syndrome is a systemic vasculitis with an unknown aetiology affecting the small and
large vessels of the venous and arterial systems. The presence of symptom clusters …
large vessels of the venous and arterial systems. The presence of symptom clusters …
Phenotypes in Behçet's syndrome
E Seyahi - Internal and emergency medicine, 2019 - Springer
Behçet syndrome (BS) is a multi-systemic complex disorder with unknown etiology and a
unique geographic distribution. It could not be possible to include it into specific …
unique geographic distribution. It could not be possible to include it into specific …